Literature DB >> 6185614

Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice.

R M Steinman, B Gutchinov, M D Witmer, M C Nussenzweig.   

Abstract

Clone 33D1 is a mouse-rat hybridoma that secretes a specific anti-dendritic cell (DC) monoclonal antibody (14). Because the antibody kills DC in the presence of rabbit complement, it can be used to study the functional consequences of selective DC depletion. Previous data on the cell specificity of 33D1 were first extended. By cytotoxicity (rabbit complement) and indirect immunofluorescence (biotin-avidin technique), 33D1 reacted with DC but not with macrophages nor other splenocytes. In contrast, the monoclonal antibody, F4/80 (15), reacted with macrophages but not DC. The functional assay evaluated in this paper was stimulation of the primary mixed leukocyte reaction (MLR). 33D1 antibody itself did not inhibit stimulation by enriched populations of DC. In the presence of complement, 33D1 killed DC and ablated stimulatory function. The effect of 33D1 and complement on MLR stimulation by heterogenous cell mixtures was then evaluated. Removal of DC from unfractionated spleen suspensions reduced stimulatory capacity 75-90 percent, comparable to that produced with specific anti-Ia antibody and complement. Stimulation of both proliferative and cytotoxic responses was reduced. DC depletion had similar effects on MLR generated across full strain differences, or across selected subregions (H2I, H-2K/D) of the major histocompatibility complex. To further compare the functional properties of spleen DC and macrophages, MLR stimulation by adherent and nonadherent fractions of spleen were tested separately. 62 +/- 8 percent of the total stimulatory capacity of spleen was in the plastic adherent population. Activity was ablated greater than 90 percent after elimination of DC. MLR stimulation by 24-h cultures of spleen adherent cells, which contained a three- to sixfold excess of Ia(+) macrophages, was also ablated when DC were removed. Stimulation by nonadherent spleen was more resistant, but was reduced 50-75 percent by 33D1 and complement. The function of spleen cells treated with 33D1 or anti-Ia antibody and complement was restored with a small inoculum of purified DC. The latter corresponded to 0.5 percent of total stimulator cells and were enriched by previously described techniques that did not require the 33D1 antibody. We conclude that the DC, a trace component of mouse spleen, is the principal cell type required for stimulation of the primary MLR. Because other cells are not immunogenic, but do express Ia and H-2 alloantigens, DC likely represent the critical accessory cell required for the induction of lymphocyte responses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6185614      PMCID: PMC2186925          DOI: 10.1084/jem.157.2.613

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  A monoclonal antibody specific for mouse dendritic cells.

Authors:  M C Nussenzweig; R M Steinman; M D Witmer; B Gutchinov
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

2.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

3.  Cellular interactions in the generation of cytolytic T lymphocyte responses. Analysis of the helper T cell pathway.

Authors:  O Weinberger; S Herrmann; M F Mescher; B Benacerraf; S J Burakoff
Journal:  Eur J Immunol       Date:  1981-05       Impact factor: 5.532

4.  Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants.

Authors:  D Faustman; V Hauptfeld; P Lacy; J Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

5.  Rat dendritic cells function as accessory cells and control the production of a soluble factor required for mitogenic responses of T lymphocytes.

Authors:  W E Klinkert; J H LaBadie; J P O'Brien; C F Beyer; W E Bowers
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  The rat mixed lymphocyte reaction: roles of a dendritic cell in intestinal lymph and T-cell subsets defined by monoclonal antibodies.

Authors:  D W Mason; C W Pugh; M Webb
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

7.  Dendritic cells induce T cell proliferation to synthetic antigens under Ir gene control.

Authors:  G H Sunshine; D R Katz; M Feldmann
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

8.  Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells.

Authors:  R I Lechler; J R Batchelor
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

9.  Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain.

Authors:  D N Hart; J W Fabre
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

10.  Studies of the cell surface of mouse dendritic cells and other leukocytes.

Authors:  M C Nussenzweig; R M Steinman; J C Unkeless; M D Witmer; B Gutchinov; Z A Cohn
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

View more
  94 in total

1.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.

Authors:  Steffen Jung; Derya Unutmaz; Phillip Wong; Gen-Ichiro Sano; Kenia De los Santos; Tim Sparwasser; Shengji Wu; Sri Vuthoori; Kyung Ko; Fidel Zavala; Eric G Pamer; Dan R Littman; Richard A Lang
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

Review 2.  Induction of RNA interference in dendritic cells.

Authors:  Mu Li; Hua Qian; Thomas E Ichim; Wei-Wen Ge; Igor A Popov; Katarzyna Rycerz; John Neu; David White; Robert Zhong; Wei-Ping Min
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 3.  Tolerogenic dendritic cells and their potential applications.

Authors:  Jim Hu; Yonghong Wan
Journal:  Immunology       Date:  2011-01-05       Impact factor: 7.397

Review 4.  Antigen presenting cells.

Authors:  D L Hamilos
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

5.  The in-vitro inhibition of rat alloantigen presentation by immunotoxins--implications for allografting.

Authors:  K N Wiley; A Clark; M Fox
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

6.  Immunoregulatory properties of bone marrow-derived cells in the iris and ciliary body.

Authors:  J S Williamson; D Bradley; J W Streilein
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

7.  Human rheumatoid synovial and normal blood dendritic cells as antigen presenting cell--comparison with autologous monocytes.

Authors:  K Waalen; O Førre; J Teigland; J B Natvig
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

8.  Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells.

Authors:  B D Hock; G C Starling; P B Daniel; D N Hart
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

9.  Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody.

Authors:  D L Faustman; R M Steinman; H M Gebel; V Hauptfeld; J M Davie; P E Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo.

Authors:  S C Knight; S Iqball; C Woods; A Stagg; M E Ward; M Tuffrey
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.